261 related articles for article (PubMed ID: 22608141)
41. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
[TBL] [Abstract][Full Text] [Related]
42. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
[TBL] [Abstract][Full Text] [Related]
43. Maternal Foxp3 expressing CD4+ CD25+ and CD4+ CD25- regulatory T-cell populations are enriched in human early normal pregnancy decidua: a phenotypic study of paired decidual and peripheral blood samples.
Dimova T; Nagaeva O; Stenqvist AC; Hedlund M; Kjellberg L; Strand M; Dehlin E; Mincheva-Nilsson L
Am J Reprod Immunol; 2011 Jul; 66 Suppl 1():44-56. PubMed ID: 21726337
[TBL] [Abstract][Full Text] [Related]
44. [Study on ratio imbalance of peripheral blood Th17/Treg cells in patients with rheumatoid arthritis].
Niu Q; Huang ZC; Cai B; Wang LL; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):267-9, 272. PubMed ID: 20230694
[TBL] [Abstract][Full Text] [Related]
45. [Expression levels of co-inhibitory molecules CTLA-4, LAG-3, PD-1 and CD39 on CD4⁺ T cells correlate with progression of non-small cell lung cancer].
Wei T; Zhang J; Wu Y; Zhang D; Lu L; Shen Q
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):424-9. PubMed ID: 25241783
[TBL] [Abstract][Full Text] [Related]
46. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancer.
Muto S; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Int J Oncol; 2015 Dec; 47(6):2082-90. PubMed ID: 26460798
[TBL] [Abstract][Full Text] [Related]
48. Myeloid and lymphoid dendritic cells and cytotoxic T lymphocytes in peripheral blood of non-small cell lung cancer patient--a pilot study.
Krawczyk P; Wojas K; Milanowski P; Roliński J
Adv Med Sci; 2006; 51():160-3. PubMed ID: 17357299
[TBL] [Abstract][Full Text] [Related]
49. [Analysis of CD4+CD25+Foxp3+ regulatory T cells in patients of haemorrhagic fever with renal syndrome].
Nie ST; Li Q; Wang HY
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):817-9. PubMed ID: 19595120
[TBL] [Abstract][Full Text] [Related]
50. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells.
Chang CC; Satwani P; Oberfield N; Vlad G; Simpson LL; Cairo MS
Exp Hematol; 2005 Dec; 33(12):1508-20. PubMed ID: 16338494
[TBL] [Abstract][Full Text] [Related]
51. The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.
Jonson CO; Hedman M; Karlsson Faresjö M; Casas R; Ilonen J; Ludvigsson J; Vaarala O;
Clin Exp Immunol; 2006 Jul; 145(1):48-55. PubMed ID: 16792673
[TBL] [Abstract][Full Text] [Related]
52. Increased numbers but functional defects of CD56+CD3+ cells in lung cancer.
Al Omar SY; Marshall E; Middleton D; Christmas SE
Int Immunol; 2012 Jul; 24(7):409-15. PubMed ID: 22366043
[TBL] [Abstract][Full Text] [Related]
53. [Level of CD4(+) CD25(high) CD127(low/-) regulatory T cells in transitional cell carcinoma patients and its clinical significance].
Zhu X; Hu XZ; Ma LL; Tian Y
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2269-72. PubMed ID: 20095340
[TBL] [Abstract][Full Text] [Related]
54. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
55. Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.
Tuve S; Chen BM; Liu Y; Cheng TL; Touré P; Sow PS; Feng Q; Kiviat N; Strauss R; Ni S; Li ZY; Roffler SR; Lieber A
Cancer Res; 2007 Jun; 67(12):5929-39. PubMed ID: 17575163
[TBL] [Abstract][Full Text] [Related]
56. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
[TBL] [Abstract][Full Text] [Related]
57. Identification and clinical relevance of naturally occurring human CD8+HLA-DR+ regulatory T cells.
Arruvito L; Payaslián F; Baz P; Podhorzer A; Billordo A; Pandolfi J; Semeniuk G; Arribalzaga E; Fainboim L
J Immunol; 2014 Nov; 193(9):4469-76. PubMed ID: 25261474
[TBL] [Abstract][Full Text] [Related]
58. [Differential analysis of lymphocyte subsets between colorectal carcinoma patients and healthy individuals].
Zhang GQ; Jiao SC; Wen XY; Zhao H; Lin XS; Wu LL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):735-7. PubMed ID: 22768866
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of peripheral blood T lymphocyte surface activation markers and transcription factors in patients with early stage non-small cell lung cancer.
Rutkowski J; Cyman M; Ślebioda T; Bemben K; Rutkowska A; Gruchała M; Kmieć Z; Pliszka A; Zaucha R
Cell Immunol; 2017 Dec; 322():26-33. PubMed ID: 28939130
[TBL] [Abstract][Full Text] [Related]
60. [Alterations of lymphocyte subsets and indicators of immune suppression in patients with acute pancreatitis].
Zhulai GA; Oleinik EK; Ostrovskii KA; Oleinik VM; Kravchenko PN; Churov AV
Eksp Klin Gastroenterol; 2014; (9):21-5. PubMed ID: 25916128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
